Alligator Bioscience AB (7AL0) Stock Statistics & Valuation Metrics

Alligator Bioscience AB has a market cap or net worth of €9.16M. The enterprise value is €5.52M.

Alligator Bioscience AB has 534,516,970 shares outstanding. The number of shares has decreased by -2.65% in one year.

Alligator Bioscience AB’s return on equity (ROE) is -7.49 and return on invested capital (ROIC) is -244.42%.

The current PE Ratio of Alligator Bioscience AB is ―. Alligator Bioscience AB’s PEG ratio is 0.00194.

In the last 12 months, Alligator Bioscience AB had revenue of 514.00K and earned -51.35M in profits. Earnings per share was -1.87.

In the last 12 months, operating cash flow was -137.83M and capital expenditures 0.00, giving a free cash flow of -137.83M billion.

Alligator Bioscience AB pays an annual dividend of ―, resulting in a dividend yield of ―

Alligator Bioscience AB upcoming earnings date is Aug 27, 2026, TBA (Confirmed).

Alligator Bioscience AB as a current ratio of 0.88, with Debt / Equity ratio of 78.45%

In the past 12 months, Alligator Bioscience AB has paid 0.00 in taxes.

Alligator Bioscience AB EV to EBITDA ratio is 0.08, with an EV/FCF ratio of 0.06.

Alligator Bioscience AB has €32.98M in cash and marketable securities with €32.38M in debt, giving a net cash position of €597.00K billion.

Gross margin is -8152.57%, with operating margin of -23780.54%, and net profit margin of -9990.27%.

The average price target for Alligator Bioscience AB is ―, which is 11.43% higher than the current price. The consensus rating is ―